Gene therapy is a type of treatment that involves modifying the genes of cells to treat or prevent diseases. It is a rapidly evolving field that has potential applications for many conditions.

CHALLENGE

The client sought to understand the Canadian gene therapy landscape, including the regulatory environment, market access opportunities, and potential barriers, to effectively position their innovative gene therapy product.

OBJECTIVE

Equip the client with a comprehensive gene therapy landscape assessment, identifying key opportunities and challenges to support their market access strategy in Canada while instilling confidence and security in their approach.

APPROACH

Our team of payers and HTA professionals with extensive and unique first-hand experience thoroughly analyzed the Canadian gene therapy market. This involved:

  • Reviewing the regulatory framework and recent approvals in the gene therapy space.
  • Analyzing reimbursement policies and payer perspectives on gene therapy products, leveraging our unique system insider insights.
  • Identifying key stakeholders and their roles in the gene therapy landscape.
  • Assessing the competitive landscape and potential market positioning strategies.

SOLUTION

We delivered a comprehensive, customized report that provided the client with actionable insights into the Canadian gene therapy landscape, which included:

  • An overview of the regulatory environment and its implications for the client’s product.
  • A summary of market access challenges and opportunities for gene therapy products, fostering a common understanding between industry and public sector perspectives.
  • Identifying key stakeholders and their roles in the gene therapy landscape.
  • Insights on stakeholder engagement and strategies for building solid relationships with key players in the market, highlighting our collaborative and client-centric approach.

KEY RESULTS

Our landscape assessment helped the client understand the Canadian gene therapy market and its intricacies from a payer and HTA perspective. Our unique insights and collaborative approach made them feel confident and secure in their market access strategy, product positioning, and stakeholder engagement efforts, setting the stage for a successful product launch.

CONCULSION

MORSE Consulting’s expert analysis of the gene therapy landscape in Canada provided valuable insights and strategic guidance for the client, equipping them with the necessary tools to navigate the complex market and optimize their innovative gene therapy product’s potential. Our unparalleled first-hand payer and HTA expertise, creative solutions, and genuine commitment to our client’s success made a significant difference in their market access journey.

FEEDBACK ON THIS CASE STUDY

“The team at MORSE provided a comprehensive overview of the gene therapy landscape in Canada across the relevant stakeholders including Health Canada, CADTH, INESSS, provincial payers and private payers. They were able to leverage the strong expertise of their in-house team, as well as their external strategic partners, to provide diverse and informed insights about every step of the process. They were flexible and adaptable as the project scope evolved and delivered a highly detailed, informative, and interactive presentation of their findings. The outputs of this project have proven to be highly valuable in helping our organization better prepare for the opportunities and challenges of bringing novel gene therapies to Canada.”

– Director of Market Access
Toronto-Based Pharmaceutical Company

If your team has specific needs related to any of our Canadian Gene Therapy Landscape Assessment services, MORSE has the flexibility to customize its service offerings to meet those needs. Contact MORSE today at info@morseconsulting.ca

New Case Study: Canadian Gene Therapy Landscape Assessment